GB2197653A - Gene fusion comprising beta -glucuronidase - Google Patents
Gene fusion comprising beta -glucuronidase Download PDFInfo
- Publication number
- GB2197653A GB2197653A GB8725852A GB8725852A GB2197653A GB 2197653 A GB2197653 A GB 2197653A GB 8725852 A GB8725852 A GB 8725852A GB 8725852 A GB8725852 A GB 8725852A GB 2197653 A GB2197653 A GB 2197653A
- Authority
- GB
- United Kingdom
- Prior art keywords
- gene
- gus
- beta
- glucuronidase
- activity
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01031—Beta-glucuronidase (3.2.1.31)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
- C12N15/8209—Selection, visualisation of transformants, reporter constructs, e.g. antibiotic resistance markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2434—Glucanases acting on beta-1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Medicinal Chemistry (AREA)
- Cell Biology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
A gene fusion product comprises a gene coding for beta-glucuronidase (GUS), eg the uidA gene of E. coli, and can be used in the introduction, monitoring and regulation of expression of a desired gene in hosts such as plants, animals, yeasts etc. Plasmids containing the beta-glucuronidase gene and N-terminal sites for insertion and fusion of desired gene are disclosed.
Description
Gene Fusion
Field of invention
This invention relates to qene fusion and concerns novel gene fusion products and plasrnids and the use thereof eq in monitoring gene expression.
Background t the invention
The use of fusions between a gene of interest and a repurter qene with an easily detectable product offers several advantages for the study of gene expression.
Control of gene activity can be manifested at many levels, including the initiation of transcription or translation, the processing, transport or degradation of mRNA or protein. The use of precise gene fusions can simplify analysis of this complex process and delineate the contribution of transcriptional control by eliminating the specific siqnals for post-transcriptional controls and replacing them with sequences from a readily asssayed reporter gene.
The use of a sinqle set of assays to monitor the expression of diverse gene control regions simplifies analysis and often enhances the sensitivity with which measurements of gene activity can be made. Many genes in higher orqanisms are members of gene families consisting of several related genes whose expression may be
indenendently controlled (see reference 1). It is often
desirable to study the expression of one member of such a qene family free from the backqround of the other members of the family. The use of in vitro qenerated gene fusions
and nNA transformation permits such an analysis.
Further, members of multi-gene families whose products are very similar can he reaulated differentially during development. By usinq gene fusions to individual members of such families and introducinq these fusions into the germline, it is nossible to study the expression of
individual aenes senarate from the background of the other members of the gene family. Additionally, analysis of mutationally altered genes in organisms accessible to transformation techniques is qreatly facilitated by the use of sensitive reporter enzymes.By using a reporter gene that encodes an enzyme activity not found in the organism beina studied, the sensitivity with which chimeric gene activity can be measured is limited only by the Properties of the reporter enzyme and the Quality of the availahle assays for the enzyme.
The most frequency used reporter gene is probably the E.
coli lacZ aene, encoding a beta-galactosidase (see references 2, 3). Beta-galactosidase has many features that make it attractive as a gene fusion marker. The gene and aene product are well characterised genetically and biochemically (see reference 3). There are sensitive assays for the enzyme that utilise commercially available substrates, including several that allow visualisation of enzyme activity in situ. Beta-galactosidase is not, however, ideal for all systems. There are several intensively studied bioloaical systems (eq tobacco plants) in which endugenous beta-galactosidase levels are hiah enough for it to he difficult or impossible to detect chimacric heta-qalactusidase by enzymatic methods.In addition the enzyme and gene are very large, sometimes making the in vitro construction and analysis of gene fusions unwieldy.
these of the Agrobacterium tumefaciens Ti-plasmid-encoded genes nopaline synthase (see references 4, 5) and octopine synthase (see reference 6) promised to overcome problems associated with endogenous activity as the opines produced by these genes are not found in normal plant cells. nut because the assays are cumbersome and difficult to quantitate, cannot be used to demonstrate enzyme localisation (see reference 7), and octopine synthase cannot tolerate amino-terminal fusions (see reference R) these reporter genes are not widely used.In addition the catabolism of opines by Aqrobacterium often present in transformed plant tissue makes the interpretation of opine levels difficult in experiments where opine synthases are used as reporter genes (see reference 9).
The two most useful reporter genes have been the bacterial genes choloramphenicol acetyl transferase (CAT) and neomycin phophotransferase (NPTII) which encode enzymes not normally found in plant tissues (see references 10, 11, 12, 13). In addition NPTII can tolerate large aminoterminal fusions and remain enzymatically active, making it useful for studyinq organelle transport in plants (see reference 14). However both CAT and NPTII are relatively difficult, tedious and expensive to assay and suffer from variable endogenous activities in plant cells, which limits their sensitivity (see references 15, 16).In addition, competing reactions catalyzed hy endoaenous esterases, shosphatase.m, transferases and other enzymes also limits sensitivitv and makes quantitaion of CAT or
NPTII by enzyme kinetics very difficult.
Recently, the firefly luciferase qene has been used as a marker in transqenic slants (see reference 60), hut the enzyme is table and difficult to assay with accuracy (see reference 61), the reaction is complex and there is little, if any, Potential for routine histochemical analvsvs or fusion aenetics.
Summarv of the invention
The invention provides a new gene fusion system that uses a qene coding for beta-glucuronidase as the reporter qene.
Thus in one aspect the present invention provides a qene fusion product comprising a gene coding for beta qlucuronidase (CUS).
Beta-glucuronidase (GUS) is an acid hydrolase that catalyzes the cleaveaae of a wide variety of betaglucuronides (see reference 36). Substrates for betaglucuronidase are generally water soluble, and due to the extensive analysis of mammalian qlucuronidases (see reference 17) many substrates are commercially available, including substrates for spectrophotometric, fluorometric and histochemical analyses. This ability to perform histochemical analysis of gene fusions is an important feature for the study of gene expression in metazoa and plants, where spatial discrimination is often essential for assessing the regulation of genes. Methods have been described that allow subcellular localisation of glucoronidase activity (reviewed in reference 18).
The invention may use a gene coding for GUS obtained from a wide variety of sources, including micro-organisms, animals such as mammals etc. It is currently preferred to use the uidA gene of E. coli for this purpose as must work so far has been carried out using this gene.
The uidA gene has been analyzed genetically and was shown by Novel et al to encode the beta-glucuronidase structural gene (see references 19, 20, 21, 22). The gene has now been fully sequenced and is found to encode a stable enzyme that has desirable properties for the construction and analysis of gene fusions.
The gene coding for GUS is conveniently under control of a suitable promoter, such as the E. coli lacZ promoter.
Por example, gene fusions of the E. coli lacZ promoter and coding region of the uidA gene have been constructed and show GUS activity under lac control.
Gene fusions using the cauliflower mosaic virus (CaMV) 35S promoter or the promoter from the small subunit of ribulose bisphosphate carboxylase (rbcS) and the qene coding for GUS have also been constructed. With such products the promoters have been shown to direct expression of GUS in transformed plants.
In a further aspect, the invention also provides a plasmid comprising a gene coding for GUS.
Such a plasmid may conveniently be constructed from plasmids such as pRIN19. A range of such plasmids may be produced, including those known as p5I1Ol, including psI101.1 (previously known as nTAK1) (Deposited with
National Collection of Industrial Bacteria (NCIn) under accession Nu. 12353), pBI101.2 (previously known as pTAK2) (NCIP accession No. 12354), and pnI101.3 (previously known as pTAK3) (NCIB accession No. 12355).
The PRI101 plasmids contain many different restriction sites (eq for Hind III, Sal I, Xba 1, RamH 1 and Sma I) upstream of the AUG initiator code of GUS, to which promoter DNA fragments can he conveniently ligated. For example the CaMV 35S promoter may be ligated into the Hind
III and RamH 1 sites tu create a plasmid known as pBI121 (previously knows as pCTAKl). Similarly, the promoter from a tobacco ribulosebisphosphate carboxylase small subunit gene, d23 deleted of rbcS coding sequences fused to pBI101.1 makes a olasmid known as pPI131 (previously known as pSSU8TAK1).
Plasmids in accordance with the invention, Darticularly the DPI101 and related olasmids, are suitable for transcriptional or translational fusions, the latter possibility permitting additional proteins to he produced in a host whilst retaining enzyme activity of GUS.
The 3 pBI101 vectors differ hv 1 or 2 initial nucleotides, permitting protein fusions to he constructed in all 3 reading frames.
The pPI101 and related niasmids incorporate the GUS coding sequence in a format that is easy to manipulate and transfer into hosts, narticularly Dlants.
The products of the invention can be introduced to hosts such as nlants, animals, veasts, etc and are useful for munitorin and manipulating gene expression in such recipients.
Hence in a further aspect, the invention provides a method of introducing a gene of interest to a host, comprising introducing to the host a gene fusion product comprising a gene coding for GUS and the gene of interest.
The invention can thus be used to introduce useful genes to a host eg conferring desirable properties such as disease resistance etc on the host.
The present invention also provides a method of monitoring expression of a gene of interest in a host, comprising introducing to a host a gene fusion product comprising a gene coding for GUS and the gene of interest, and monitoring to detect the presence of GUS.
Expression of the gene of interest also results in expression of GUS. Provided no other source of GUS is present, the nresence of GUS indicates expression of the gene of interest.
The monotiring may he carried out qualitatively or quantitively as approDriate, ea using spectrophotometric, fluorometric or histochemical assays.
Possible hosts include plants, animals, yeasts or other micro-oraanisms, and assays can be carried out both in vivo and in vitro.
The invention also includes within its scope a transformed host to which has been introduced a gene fusion product comprising a gene coding for GUS.
Products of such a transformed host, eq seeds of a transformed plant, are also included within the scope of the invention.
Gene fusion products in accordance with the invention may also be used as genetic markers in conventional plant breeding techniques such as restriction fragment length colymorphism (RFLP) techniques.
GUS is a bichly suitable enzyme for use in study of cene expression and use of GUS gene fusions can allow analysis of genes whose products are of moderate and low abundance.
Activity of the reporter enzyme is maintained when fused to other proteins at its amino terminus, allowing the study of translation and the processing events involved in protein transport. The reporter enzyme is detectable with sensitive histochemical assays, enabling localisation of gene activity in particular cell types. Finally. the reaction catalyzed by the reporter enzyme is sufficiently soecific to minimize interference with normal cellular metabolism and general enough to allow the use of a variety of novel substrates to maximise the potential fo fusion genetics and in vivo analysis.
The GUS gene has several features that make it particularly useful as a reporter gene for plant studies.
All nlants tutus L05 far assayed lack detectable glucuronidase activity, providing a null background in which to assay chimaeric gene expression. Further, the enzyme is easily, sensitively and cheaply assayed both in vitro and in gels, and can also he assayed histochemically to localise GUS activity in cells and tissues. For example, it has been found that a ffuorometric GUS assay can cost as little as 1/2000 of the cost of a comparable CAT assay, while giving increased sensitivity.
Expression of GUS can be accurately measured using fluorometric assays of trace amounts of transformed plant tissue. Plants expressing GUS are normal, healthy and fertile. GUS is very stable, retaining activity after electrophoresis on SDS polyacrylamide gels, and extracts continue to show high levels of glucuronidase activity after prolonged storage.
The invention will be further described, by way of example, with reference tu the accompanying drawings, in which:
Figure 1 illustrates subcloning and strategy for determining the nucleotide sequence of the uidA gene;
Figure 2 illustrates the DNA sequence of the 2439 bp insert of pRAJ220, containing the beta-glucuronidase gene;
Figure 3 illustrates GUS gene module vectors:
Figure 4 illustrates the results of 7.5t SDS-PAGE analysis of beta-glucuronidase;
Figure 5 illustrates structures of the col-1:GtS fusion (pRAJ321) and the MSP::GUS fusion (pRAJ421); Figure 6 shows the results of assaying beta-glucuronidase activity in transformed worms;
Figure 7 illustrates the results of co-segregation analysis of heta-glucuronidase activity and transforming
DNA;
Figure 8 illustrates histochemical visualisation of betaglucuronidase activity in worms transformed with the col1:GUS fusion (nRAJ321); Figure 9 illustrates the structure of expression vectors;
Figure 10 is a graph illustrating beta-glucuronidase activity in extracts of different organs of transformed and non-transformed tobacco nlants; figure 11 is an auturadiograph of a Southern blot of DNA extracted from transformed plants and dines ted with restriction endonucleoses; and
Figure 12 illustrates 7.58 SDS-polyacrylamide gel stained for beta-glucuronidase activity.
Materials and Methods
DNA Manipulation Restriction enzymes and DNA modifying enzymes were obtained from New Enqland Riolabs whenever possible, and used as per the instructions of the manufacturer. Plasmid DNA preparations were done by the method of Birnboim and Duly (see reference 25) as described in the Maniatis et al (see reference 26). Routine cloning procedures, including ligations and transformation of . Coli cells, were nerformed essentially as described in reference 26. DNA fragments were nurified from agarose aels bv electrophoresis onto Schleicher & Schuell NA 45 nEAF membrane (see reference 27) as recommended by the manufacturer.DNA sequences were determined by the dideoxy chain terminator method of Sanger and Coulson (see reference 28) as modified by Biggin et al (see reference 29). Oligonucleotide primers for sequencinq and sitedirected mutaqenesis were synthesised using an Applied
Biosystems DNA synthesiser, and purified by preparative polyacrylamide gel electrophoresis. Site directed mutagenesis was performed on ssDNA obtained from pEMBL derived zlasmids, essentially as described in reference 30. The strain used for routine manipulation of the uidA gene was RJ21, a recA derivative of JM83 (see reference 31) generated hy P1 transduction. Strain PK803 was obtained from P. Reumpel of the University of Colorado at
Boulder, and contains a deletion of the manA - uidA region.Plasmid vectors pUC7, 8 and 9 (see reference 11) and pEMBL (see reference 32) have been described.
Protein sequencing and amino acid analysis
Sequence analysis was performed hy Dr A Smith of the
Protein Structure Laboratory, University of California,
Davis, using a Beckman 890M spinning-cup sequenator.
Amino acid composition was determined by analysis of acid hydrolyzates of purified beta-glucuronidase on a Beckman 6300 amino acid analyser.
Protein analysis
Protein concentrations were determined by the dye-binding method of Bradford (see reference 33) using a kit supplied by RIO-RAD Laboratories. Sodium dodecyl sulphatepolyacrylamide gel electrophoresis (SDS-PAGE) was performed using the Laemmli system (see reference 34).
Beta-glucuronidase assays
Glucuronidase was assayed in a buffer consisting of 50 mM NaPO4, pH 7.0, 10mM B-ME, 0.1% Triton X-100, 1 mM pnitrophenyl beta-D-glucuronide. Reactions were performed in one ml. volumes at 370C, and terminated hy the addition of 0.4 ml 2.5 M 2-amino-2-methyl propanediol. pnitronhenol absorbance was measured at 415 nm. Routine testing of bacterial colonies for beta-glucuronidase activity was done by transfering bacteria with a toothpick into microtiter wells containing the assay buffer. The histochemical substrate 5-bromo. 4-chloro, 3-indolyl beta
D-glucuronide (analogous to the beta-galactosidase substrate X-gal) is commercially available (Research
Organics Inc.Cleveland, Ohio), and is found tu he an excellent and sensitive indicator of beta-glucuronidase activity in situ when included in aar plates at a concentration of 50 ua/ml.
Purification of beta-glucuronidase
Beta-glucuronidase was purified hy conventional methods from the strain RJ21 containing the nlasmid pRAJ210.
figure 1 illustrates subclonina and strategy for determining the nucleotide sequence of the uidA gene.
Briefly, pBKuidA was generated by cloning into pBR325.
nRAJ2l0 and pRAJ220 were generated in pUC9, with the orientation of the uidA gene opposite to that of the lac% gene in the vector. The sequence was determined from both strands for all of the region indicated except from nucleotide 1 or 125. The orientation of the coding region is from left tu right.
Results
Subcloning and Sequencing of the uidA gene
The starting point for the subcloning and sequencing of the beta-glucuronidase gene was the plasmid n5KuidA shown in Figure 1. pBKuidA has been shown to complement a deletion of the uidA - manA region of the F. coli K-12 chromosome restoring beta-glucuronidase activity when transformed into the deleted strain, PK803. The strategy for the localisation of the gene on the insert is shown in
Figure 1.
A restriction map of the insert was obtained, and various subclones were generated in the plasmid vector pUC9, and tested for their ability to confer beta-glucuronidase activity upon transformation of PK803. The intermediate plasmid pRAJ210 conferred high levels of glucuronidase activity on the deleted strain, and was used for the purification of the enzyme. Several overlapping subclones contained within an 800 base pair (bp) Eco RI - Bam HI fragment conferred high levels of constitutive betaglucuronidase production only when transformed into a uidA + host strain, and showed no effect when transformed into PK803.
It is surmised that the 800 bp fragment carried the operator region of the uidA locus, and was possibly titrating repressor to give a constitutively expressing chromasomal uidA gene. With this information to indicate a probable direction of transcription, and a minimum gene size estimate obtained from characterisation of the purified enzyme (see below), a series of RAL 31 deletions were generated from the Xho 1 site of nRAX210. The fragments were gel purified, liqated into pUC9 and transformed into PK803. The resulting colonies were then assayed for beta-glucuronidase activity.
The smallest clone obtained that still gave constitutive levels of heta-glucuronidase was PRAJ220, which contained a 2.4 kilobase pair (kb) insert. Subclones of this 2.4 kb fragment were generated in M13mp8 and mp9 and their DNA sequence was determined as ilustrated in Figure 2.
Figure 2 shows the DNA sequence of the 2439 bp insert of pRAJ220, containing the beta-glucuronidase gene. The arrows before the coding sequence indicate regions of dyad symmetry that could be recognition sequences for effector molecules. The overlined region is the putative
Shine/Dalgarno sequence for the uidA gene, while the brackets indicate two nossible Pribnow boxes. All of the palindromic regions fall within the smallest subcloned region (from the Sau 3A site at i66 to the Hinf I site at 291) that qave constitutive genomic expression of uidA when nresent in high copy in trans, consistent with their proposed function as renressor binding sites.The terminator codun at 2106 overlaps with an ATG that may be the initiator codon of a second open reading frame, as indicated (see Discussion).
Manipulation of the uidA gene for vector construction
The clasmid pRAJ220 contains the nromoter and operator of the E coli uidA locus, as well as additional out-of-frame ATG colons that would reduce the efficiency of proper translational initiation in eukaryotic systems (see reference 35). It was necesary to remove this DNA to facilitiate using the structural gene as a reporter module in gene fusion experiments. This was done by cloning and manipulating the 5' region of the qene separately from the 3' region, then rejoininq the to parts as a lacZ:uidA fusion that showed beta-glucuronidase activity under lac control.The resulting plasmid was further modified by progressive subcloning, linker additions and site-directed mutagenesis to generate a set of useful gene module vectors. These manipulations are illustrated by reference to Figure 3, which shows GUS gene module vectors.
As illustrated in Figure 3, pRAJ220 (see Figure 1) was digested with Hinf I, which cleaves between the
Shine/Dalgarno sequence and the initiator ATG, the singlestranded tails were filled-in, digested with Bam HI and the resulting 515 bp fragment was gel purified and cloned into pUC9/Hinc II and Ram HI. This plasmid was digested with Bam HI and the 3' region of the uidA gene carried on a 1.6 kb Ram HI fragment from pRAJ220 was ligated into it.
The resulting plasmid, pRAJ230, showed IPTG inducible GUS activity when transformed into JM103. sRAJ230 was further modified by the addition of Sal 1 linkers to generate pRAJ240, an in-frame lacZ:uidA fusion in pUC7. pRAJ230 was digested with Aat II, which cuts 45 bp 3' to the uidA translational terminator, the ends were filled, digested with Pst I, and the resulting 1860 bp fragment was gel purified, and cloned into pEMBL9/Pst I and Sma I. The resulting plasmid, pRAJ250, is an in-frame lacZ:uidA fusion. The Bam HI site that occurs within the coding region at nucleotide 807 was eliminated by oligonucleotide-directed mutagenesis of single-stranded
DNA prepared from pRAJ250, changing the Bam HI site from
GGATCC to GAATCC, with no change in the predicted amino acid sequence.The clone resulting from the mutagenesis, pRAJ255, shows normal GUS activity, and lacks the Dam HI site. This plasmid was further modified by the addition o a Pst I linker to the 3' end and cloned into pEMRL9/Pst
I, to generate pRAJ260.
Purification and properties of beta-glucuronidase Beta-glucuronidase activity in E. coli is induced by a variety of beta-glucuronides; methyl c'lucuronide is among the must effective (see reference 36). To determine the size and properties of the enzyme and to verify that the enzyme produced by the clone pRAJ210 was in fact the ni-oduct of the uidA locus, the protein was purified from the over-producing strain, and the purified product was compared with the enzyme induced from the single genomic locus by methyl glucuronide.
Aliquots of supernatants from induced and uninduced cultures of E. coli C600 were analysed by SDS-PAGE and compared with. aliguots of the purified beta-glucuronidase as shown in figure 4. In Figure 4 lane (a) is molecular weight standards; lane (b) is extract from uninduced C600; lane (c) is extract from C600 induced for betaglucuronidase with 'ieGlcU (see reference 23); lane (d) is 0.3 ug of purified beta-glucuronidase (calculated to contain the same activity as the induced extract); lane (e) is 3.0 us aliquot of purified beta-glucuronidase.
The induced culture of C600 shows only a single band difference relative to the uninduced culture. The new band co-migrates with the purified beta-glucuronidase, indicating that the enzyme purified from the over producing plasmid has the same subunit molecular weight as the wild-tyne enzyme.
The purified enzyme was analysed for amino acid composition and subject to eleven cycles of Adman degradation to determine the amino terminal sequence of amnio acids. The amino acid composition agrees with the predicted composition derived from the DNA sequence, and the determined amino acid sequence agrees with the predicted sequence, identifying the site of translatiunal initiation and indicating that the mature enzyme is not processed at the amino terminus.
F. coli beta-glucuronidase is a very stable enzyme, with a broad pil optimum (from pH 5.0 to 7.5); it is half as active at pH 4.3 and pH 8.5 as at its neutral optimum, and it is resistant to thermal inactivation at 500C.
Discussion
Molecular analysis of the uid locus
The complete nucleotide sequence of the E. coli uidA gene, encoding beta-glucuronidase, has been determined. The coding region of the gene is 1809 bp long, giving a predicted subunit molecular weight for the enzyme of 68,200 daltons, in agreement with the experimentally determined value of about 73,000 daltons. The translational initiation site was verified by direct amino acid sequence analysis of the purified enzyme.
Genetic analysis of the uidA locus has shown three distinct controlling mechanics, two repressors and a cAMP dependent factor, presumably CAP (see reference 22). The
DNA sequence determined includes three striking regions of dyad symmetry that could he the bindinq sites for the two repressors and the CAP protein. One of the sequences matches well with the consensus sequence for CAP binding, and is located at the same distance from the putative transcriDtional intitiation point as the CAP bindinq site of the lac promoter.It is interestina that the putative
CAP binding site overlaps one of the other oalindromic sequences, suggesting a possible antagonisitc effect of
CAP and one or both repressors.
The sequence analysis indicates the presence of a second onen reading frame of at least 340 bp, whose initiator codon overlaps the translational teminator of the uidA gene. This open reading frame is translationally active.
Although a specific glucuronide permease has been described biochemically (see reference 36), the level of genetic analysis performed un the uid locus would not have distinguished a mutation that eliminated glucuronidase function from a mutation that eliminated transport of the substrate (see refences 19, 20). All mutations that specifically eliminated the ability t qrow on a glucuronide mapped to the uidA region of the E. coli map, indicating that if there is a gene responsible for the transport of glucuronides, it is tightly linked to uidA.
By analogy to the lac operon, it is proposed that the coupled onen reading frame may encode a permease that facilitates the uptake of beta-glucuronides.
The uidA gene as gene fusion marker
Plasmid vectors have been constructed in which the uidA structural gene has been separated from its promoter/operator and Shine/Dalgarno region, and nlaced within a variety of convenient restriction sites. The GUS gene on these restriction fragments contains all of the beta-glucuronidase coding information, including the initiator codon; there are no ATGs upstream of the initiator. These vectors allow the routine transfer of the beta-glucuronidase structural gene to the control of heterologous sequences, thereby facilitating the study of chimaeric gene expression in other systems.
The uidA encoded beta-glucuronidase is functional with several combinations of un to 20 amino acids derived from the lacZ gene and/or polylinker sequences. Translational fusions to GUS have also been used successfully in transformation experiments in the nematode Caenorhabditis elegans, and in Nicotiana tabacum, giving enzyme activity with many different combinations of amino terminal structures (see below).
There are several systems currently amenable to DNA transformation in which the study of gene fusions using beta-glucuronidase as the reporter enzyme may be advantageous. Very little, if any, beta-glucuronidase activity has been detected in most higher plants, including tobacco (Nicotiana tabacum) , potato (Solanum tuberosum), and soybean (Glycine max). Fusions of beta glucuronidase to several plant genes have recently been used to monitor tissue-specific gene activity in transformed tobacco plants. There is no detectable beta glucuronidase activity in the slime mold Dictyostelium discoidum or the yeast Saccharomyces cerevisiae.Extracts from Drosophila melanogaster have shown no beta glucuronidase activity under conditions that show betagalactosidase levels several hundred-fold over background.
Fxueriments have also been performed which show the expression of transformed genes in the nematode
Caenorhabditis elgans using the gene fusion system.
Briefly, vectors consisting of the flanking regions of a cullagen gene (col-l) or a major sperm protein gene of C.
elegans fused to the Escherichia coli uidA gene, encoding beta-glucuronidase, were microinjected into worms and found to be propagated as high-copy extrachromosomal tandem arrays. Beta-glucuronidase activity was detected in transformed lines, and the activity has been shown to he dependent unon the correct reading frame of the construction and on the presence uf the worm sequences.
The enzyme activity was shown to be encoded hy the chimacric beta-glucuronidase gene by co-segregation analysis and by inactivation with specific antisera.
Expression is at a very low level, and seems to be constitutive. Histochemical techniques have been used to visualise the enzyme activity in embryos.
In particular, gene fusions between GUS and two well- characterised genes of C. elegans, col-l and 'MSP (p3L4) have been constructed. col-l is a collagen gene that is transcribed predominantly in embryos, and somewhat less in later developmental stages, and presumably encodes a component of the first larval stage cuticle (see references 37, 38).
The 1SP gene P3L4 is a transcribed member of the major sperm protein dene family, which encodes a set of ahundant, clusely related 15,000 M. proteins that are nresent only in sperm (see references 39, 40). The FlSP aenes are transcribed only during spermatogenesis, which uccurs during the fourth larval stage (L4) in hermaphrodites and in L4 and adult stages in males.
Results and Discussion
The structures of the in-frame col-l:GUS fusion pRAJ321 and the in-frame MSP:GUS fusion pRAJ421 are shown in
Figure 5. In Figure 5 both vectors are built within pUC9 (see reference 31). The hatched region is the lac-Herived sequence from pUC9. pRAJ321 is 5.8 kb pRAJ421 is 5.5 kb.
DNA manipulations were performed essentially as described in reference 26. pRAJ321 encodes the first 5 amino acids of the col-1 gene product plus 9 amino acids derived from linker sequences fused in-frame to the entire coding region of the E. coli uidA gene, and followed by the 3' intron, the translational termination codon and the polyadenylation signal from the col-l gene. The col-l promoter module extends from the Hinc II site 530 bp upstream from the transcription initiation site to a nAL31 generated breakpoint 14 bp into the protein coding sequence of col-1. This fragment cloned into the Hind III and Pst I sites of pUC9 is designated pRAJ301. pRAJ303 was generated by elimination of the promoter-proximal Pst site of pRAJ 301, and insertion of an octameric Pst I linker.The 3' intron and the polyadenylation site from the col-1 gene are contained on a 436 bp Pvu II-Hind III fragment cloned into the Sma I site of pUC9, designated pRAJ310. The 570 bp Hind III-Sal I fragment from pRAJ301 and pRAJ303 were cloned into pRAJ310 to generate the expression vectors, pRAJ311, and pRAJ313. The MSP:GUS fusion vector pRAJ421, encodes the initiator methionine of the MSP coding sequence, 9 amino acids derived from linker sequences, and the GUS coding region, followed by the translational terminator of the MSP gene and the polyadenylation signal.The promotor module extends from a Hind III site 584 bp upstream from the initiator ATG to a Hind III site 4 bp into the coding sequence. Using a
Pst I linker, this fragment was cloned into the liind III
Pst I sites of pUC9 and is designated sRAJ401. The MSP terminator module extends from the RsaI site located 8 nucleotides upstream from the translation terminator codon, to the Hind III site, a total of about 150 bp.
This fragment was shown to contain the polyadenylation site. After several manipulations, the resulting 160 bp fragment was cloned into pRAJ401 that had been digested with Ram HI and Sma I. A plasmid clone was obtained that contained the terminator in the correct orientation to the nromoter, designated pRAJ411. The uidA structural gene encoding beta-glucuronidase (GUS) was transferred into the expression vectors as a 2.1 kb Sal I fragment from the plasmid pRAJ24fl. Clones in the correct orientation were obtained, and the nucleotide sequences at the junctions were determined using specific oligonecleotide primers complementary to the 5' coding region of the uidA gene.
pRAJ421 and pRAJ321 were shown to have GUS in-frame to the sISP and col-l initiators, respectively, while GUS in pRAJ323 was shown to be out-of-frame with respect to the col-l initiator.
Plasmid DNA was injected into the distal gonal arm of adult hermaphrodite worms at a concentration of approximately 500 uq/ml, essentially as described in reference 41. The strain used was DH408, lacking glucuronidase activity (see reference 46). Lines carrying the injected DNA as hiqh-copy extrachromosomal tandem arrays were obtained from the F2 generation of the injected worms. Stability and physical properties of the tandem arrays were similar to those described in reference 41.Transformants were obtained containing either an inframe col-l:GUS fusion (pRAJ321), an out-of-frame col1 GUS fusion (nRAJ323), an in-frame MSP:GUS fusion (pRAJ42l) or a GUS-encoding plasmid containing no worm' sequences (pRAJ210).
Fluorometric assays were performed in 100 ul of 50 mM
NaPO4 (pH7.0), 1OmM beta-mercaptoethanol, 0.1% (v/v)
Triton X-100, 0.5mM-4-methyl umbelliferyl beta-D glucuronide, at 37 C, and terminated with the addition of 1 ml of 0.2 1-tQa2CO3, or 100 ul of 1 t1-Na2CO3 (for smallscale, qualitative assays). The reaction products were visualised by irradiation with 365 nm light (for qualitative assays) or by fluorescence measurements with ex nm and em n. Extracts were prepared from worms harvested from Petri plates, washed twice in M9 salts, resuspended in assay buffer without substrate and passed through a French pressure cell at 12,000lb/in2.Protein concentrations were adjusted to 20 mg/ml and 50 ul potions were assayed. Measurements were made on a
Perkin-Elmer LS-3 spectrofluorometer. Worms from the populations harvested were shown to contain the transforming DNA at similar copy number. Extracts prepared as described above were incubated with equal volumes of either neat pre-immune serum, or affinitypurified antibody directed against purified E. coli beta glucuronidase, at a concentration of 125 ug/ml for 3 h at 40C. Protein A-Sepharose was added, and the reactions were allowed to sit for 2 h at 40C. The extracts were centrifuged at 12,000g for 5 minutes, and then assayed for beta-glucuronidase.Worms were grown for enzyme assays on the E. coli strain PK803 (obtained from P Kuempel) that contains a deletion of the uidA locus and has no detectable glucuronidase activity.
Extracts were prepared from populations of transformed worms and assayed for the presence of beta-glucuronidase.
The results are shown in Figure 6.
Extracts from uninjected worms, worms carrying the out-offrame col-1:GUS fusion, or pRAJ210 showed no detectable beta-glucuronidase activity, while extracts from worms carrying either the in-frame col-1:GUS fusion or the
MSP:GUS fusion showed significant levels of enzyme activity. Reconstruction experiments with purified heta g lucuron idase in worm extracts indicated that the quantities uf enzyme in the transformed extracts were about 1 to 2ng beta-glucuronidase/mg soluble protein, assumina comparable turnover numbers of the native and chimeric enzymes (data not shown).Consistent with the extremely low enzyme levels, no transcript was detected by
Northern blut analysis, nor has an immunologically cruss- reactive protein been detected in extracts, as nudged by
Western blots, to a sensitivity of about one part in 105 (data not shown).
To verify that the beta-glucuronidase activity measured in the extracts was due to the E. coli uidA gene product, nortions of the extracts were incubated with antibody to homogeneous E. coli beta-glucuronidase or with sre-immune serum. Immune complexes were precipitated with Staph A
Sepharose, and the supernantant was assayed for beta glucuronidase activity (Figure 6). Beta-glucuronidase activity diminshed only after addition of antibody directed against purified bacterial glucuronidase; preimmune serum showed no effect.
It was possible that a small number of integrated copies of the chimacric genes was responsible for the observed enzyme activity, and that the large tandem array was inactive. To test this possibility, 40 2 worms from a transformed individual were cloned and grown to saturation on plates. Fxtracts were prepared and assayed for the presence of the transforming DNA by dot blot hydridisation, and for beta-glucuronidase activity.
The 40 F2 worms derived from a transformant carrying the col-lGUS fusion were cloned onto individual Petri plates, grown to saturation, harvested and washed, and the culture was split into 2 parts. Extracts were prepared for (a) fluorogenic beta-glucuronidase assays or (b) DNA dot blots. Glucuronidase assays were performed essentially as described in connection with Figure 6, in the wells of a
Gilson tube rack at 370 for 4 h, and visualised by addition of Na2CO3 and placing the rack on a long-wavelength ultraviolet light box.DNA dot blots were probed with 32P--lahelled pRAJ2ln. All worm cultures that gave rise to a positive signal hy DNA dot blot analysis also gave rise to glucuronidase activity, and vice versa. In several repeats of this experiment no case was observed in which strict co-segregation of the high-copy DNA and beta glucuronidase activity was not maintained.
The results are shown in Figure 7.
The high-cony transforming DNA and the enzyme activity always co-segregated, indicating that the extrachromosomal tandem array was responsible for the beta-glucuronidase activity. Identical results were obtained from transformed populations carrying either the r1SP:GUS or the col-l:GUS fusions.
To determine whether temporal regulation of the transforming DNA was occurring, extracts from staged
Dopulations of transformed worms were assayed for beta glucuronidase activity. For both the col-l :GUS fusion and the MSP:GUS fusion, specific activity of B-glucuronidase was highest in embryos, and decreased with developmental time (data not shown). The temporal pattern of expression of the col-l:GUS fusion is consistent with the available data on col-l expression as determined by DNA dot blots in Northern blots (see reference 38). However, the pattern is also consistent with a low level constitutive expression of the chimaeric gene when accounting for the near 100fold increase in the protein content of the worm during development.In the case of the major sperm gene fusion, this temporal pattern of expression is inconsistent with the normal expression of MSP genes only rlurinq the L4 stage, but is consistent with constitutive expression of the chimacric gene.
In order to visualize beta-glucuronidase activity in situ, embryos were prepared from a population of worms containing the in-frame col-1:GUS fusion and an untransformed control population, fixed and assayed histochemically for beta-glucuronidase activity.
wreeze-cracked, formaldehyde-fixed (3% (w/v) paraformaldehyde in phosphate buffer (pH 7 ) for 3 min on ice) embryos from DH408 (a) or DH408 containing pRAJ321 (b) were assayed for glucuronidase activity using naphthol-ASBl glucuronide for 6 h at 370C, and postcoupled with freshly prepared hexazonium nararosanalin (see reference 43).
The results are shown in Figure 8.
In the transformed gonulation (a), many embryos show the red precipitate characteristic of beta-glucuronidase activity, while the untransformed population (b) never shows staining. The number of positives in a given transformed population, and the intensity of staining within a population, varies considerably. Larvae and adults from a transformed population assayed under similar conditions did not show detectable staining. Perhaps because of the low levels of beta-glucuronidase in the transformed populations it has not been possible to localise the activity spatially within the embryo, either histochemically or by indirect immunofluorescence or immunocytochemistry (data not shown).Under the fixation conditions and lengthy assay times used to obtain histochemical staining of the transformed embryus (due to the low levels of beta-glucuronidase), the diffusion of the product may be preventing discrete localisation, if indeed it is occurring.
In summary, the GUS fusion system has been used to measure chimaeric enzyme levels in transformed worms. The expression of GUS in the transformed lines is dependent upon the presence of worm promoters, and on the correct readinq frame of the translational fusions used. The levels of expression in these transformants are very low, but easily measured using a fluorometric enzyme assay for beta-glucuronidase, corresponding to about one part in a million of the soluble protein in a worm extract. The transforming DNA is in the form of long extrachromosomal tandem arrays, a situation that certainly does not mimic the normal in vivo condition of the genes under study.
Possibly the structure of the arrays imposes characteristic restrains on the expression of genes within them, perahaps due to chromatin structure or a peculiarity of conformation. Is is possible that integration of the transforming DNA will allow higher levels of expression.
Methods have recently been developed to allow integration of exogenous DNA in C. elegans (see reference 44).
Integration of the vectors described here into the germline of the worm may allow resolution of whether the low level, and inappropriate developmental expression of the chimeric genes, is due tu their extrachromosomal tandem-array structure or to some other feature of the construct ions.
Experiments were also carried out to demonstrate annlicability of the GUS gene fusion system to slants.
Materials and Methods
Nucleic Acid Manipulation
DNA manipulations were nerformed essentialLy as described in reference 26. Enzymes were obtained from New England Riolabs, Boebringer or BRL.
Plant Transformation and Regeneration
Binary vectors containing CaMV-GUS fusions and rbcS-GS fusions in E. coli MC1022 were mobilized into
Agrobacterium tumefaciens LBA4404 as described in reference 45. The integrity of the vector in
Agrobacterium was verified by Preparing DNA from
Agrobacterium immediately before plant transformation using the holling method (see reference 56). Leaf discs of Nicotiana tabacum, var. Samsun were transformed using the leaf disc method (see reference 46), and transformed plants were selected on '1. medium (see reference 47) containing 100 gg/ml kanamycin. Plants were maintained in axenic culture un MS basal medium, 3@ sucrose, 200 g/ml carbenicillin and 100 ug/ml kanamycin, at approximately
2000 lux, 18 hour day, 260C.
Southern Blot Analysis
DNA was prepared from plants by phenol extraction and ethanol precipitation of plant homogenates, followed by
RNAse digestion, phenol extraction and isopropanol precipitation. Extracts were prepared from axenic tobacco plants using approximately 100 mg fresh weight of tissue ground in 500 ul extraction buffer. Ten ul of extract was
incubated at 370C in 4 ml assay buffer and 1.0 ml aliquots were withdrawn at 0, 5, 10 and 15 minutes intervals and stopped by addition to 1 ml 0.2 M Na2CO3. The
fluorescence of liberated 4-MU was determined as described. Old leaves were lower, full-expanded leaves approximately 5 cm long, while young leaves were approximately 5 mm long, and were dissected from the shoot apex.All samples we taken from the same plant (either
CaMV-GUS 21, SSU GUS 2 or non-transformed) at the same time. DNA samples (10 ug) were digested with restriction endonucleases, electrophoresed in an 0.8% agarose gel and blotted onto nitrocellulose (see reference 26). Filters were were hybridised with oligomer-primed, 32p labelled GUS gene fragment (see reference 57) and then washed with 0.2X
SSC at 650C.
Substrates
Substrates included: 4-methyl umbelliferyl glucuronide (MUG) (Sigma M-9130), 5-bromo-4-ch1oro-3-indulyl beta-D glucuronide (X-GLIJC) (Research Organics Inc., 4353E. 49th
St, Cleveland, Ohio, USA), resurufin glucuronide (ReG)
(Molecular Probes Inc., 4849 Pitchford Ave, Gene, Oregon, tJSA).
Lysis Conditions
Tissues were lysed for assays into 50mM NaH2PO4 pH7.0, 10 mrl EDTA, 0.18 Triton X-100, 0.1% sodium lauryl sarcosine, 10 mM beta-mercaptoethanol (extraction buffer) by freezing with liquid nitrogen and grinding with mortar and pestle with sand or glass heads. Disposable pestles that Eit into Eppendorf tubes (Kontes Glass) proved useful for homogenizing small bits of tissue (eg leaf). Extracts can be stored at -700C with no loss OF activity for at least two munths. Storage of extracts in this buffer at -20 C should be avoided, as it seems to inactivate the enzyme.
Spectrothotometric Assay
For samples containina reasonably large amounts of betaglucuronidase activity, the colorometric assay can be used, monitoring the appearance of yellow colour with time. Turbidity of colour in the extract can severely limit sensitivity. For a 1 ml reaction volume: 50 mM
NaPO4 pH 7.0, 10 mM beta-mercactoethanol 1mM EDTA, 1 mM pnitrophenyl glucuronide, 0.1% Triton X-100. Incubate at 37 C. The reaction is terminated hv the addition of 0.4 ml of 2-amino, 2-methvl promanediol (Sigma A-9754).
Absorbance is measured at 415 nm against a substrate hlank (or if turbudity of the extract is a problem, against a stopped blank reaction to which an identical amount of extract has been added). Under these conditions the molar extinction coefficient of p-nitrophenol is assumed to he 14,000, thus in the 1.4 ml final volume, an absorbance of 0.010 renresents one nanomole of product produced. One unit is defined as the amount of enzyme that nroduces one nanomole of product/minute at 370C. This represents about 5 ng of pure beta-qlucuronidase.
Fluorometric Assay
For a review of fluorescence techniques, see reference 48. The fluorogenic reaction is carried out in 1 mM 4methyl-umbelliferyl glucuronide in extraction buffer with a reaction volume of 1 ml. The reaction is incubated at 370C, and 200 ul aliquots are removed at zero time and at subsequent times and the reaction terminated with the addition of 0.8 ml 0.2 M Na2CO3. The addition of Na2CO3 serves the dual purposes of stopping the enzyme reaction and developing the fluorescence of MU, which is about seven times as intense at alkaline pH. Fluorescence is then measured with excitation at 365 nm, emission at 455 nm on a Kontron SFM 25 Spectrofluorimeter, with slit widths set at 10 nm.The resulting slope at MU fluoresence versus time can therefore be measured independently of the intrinsic fluorescence of the extract. The fluorimeter should be calibrated with freshly prepared 4-methyl umbelliferone (MU) standards of 100 nanomolar and 1 micromolar MU in the same buffers.
Fluuresence is linear from nearly as low as the machine can measure (usually 1 nanomolar or less) up to 5 - 10 micromolar 4-methyl umbelliferone.
A convenient and sensitive qualitative assay can be done hy Dlacing the tubes on a long-wave UV light box and observinq the blue fluorescence. This assay can he scaled down easily tu assay very small volumes (reaction volume 50 ul, terminated with 25 ul 1M Na2CO3) in microtiter dishes or Eppendorf tubes.
If the intrinsic fluorescence of the extract limits sensitivity, it is possible to use other fluorogenic substrates. In particular, resorufin glucuronide has a very high extinction coefficient and quantum efficiency, and its excitation (560nm) and emission (590nm) are conveniently in a range where plant tissue does not absorb or fluoresce heavily. In addition, it fluoresces maximally at neutral pH, makina it unnecessary to stop the reaction.
Protein concentrations of plant extracts and of purified beta-glucuronidase were determined by the dye-binding method of Bradford (reference 33), with a kit supplied by
BIO-RAD Laboratories.
DNA concentrations in extracts were determined by measuring the fluorescence enhancement of Hoechst 33258 dye as described in reference 58, with the calibrations performed hy addition of lambda DNA standards to the extract to eliminate quenching artefacts.
In situ localisation of GUS activity in SDS polyacrylamide aels Plant extracts (1-50 ul) were incubated with 2 volumes of
SDS Sample buffer at room temperature for approximately 10 - 15 minutes and then electrophoresed on a 7.5 acrylamide
SDS ael (see reference 34) overnight at 50 mA, or in a mini-gel apparatus (BIO-RAD) for 45 minutes. The gel was then rinsed 4 times with gentle agitation, in 100 ml extraction buffer for a total of 2 hours, incubated on ice in assay buffer (containing MUG) for 30 minutes, then transferred to a qlass plate at 370C. After approximately 10 - 30 minutes at 370C, depending on the sensitivity required, the gel was sprayed lightly with 0.2 M Na2CO3 and observed under long wavelength UV transillumination.
Gels were photographed using a Kodak 2E Wratten filter.
For maximum sensitivity and resolution, it is important to allow the reaction at 370C to proceed without liquid on the surface of the gel because the product of the reaction is very soluble, and will diffuse.
Histochemical Assay
Sections were cut by hand from unfixed stems of plants grown in vitro essentially as described in reference 49, and fixed in 0.3% formaldehyde in l0mM MFS pH 5.6, 0.3M mannitol for 45 minutes at room temperature, followed by several washes in 50m NaH 2PO4, pH 7.0. All fixatives and substrate solutions were introduced into interstices of sections with a brief (about 1 minute) vacuum infiltration.
A good review of histochemical techniques and the caveats to their utilisation and interpretation can be found in
Pearse (see reference 18). Substrates for histochenical localisation include the indigogenic dye 5-bromo-4-chloro3-indolyl qlucuronide (X-Gluc), and napthol ASBI glucuronide.
Histochemical reactions with the indigogenic substrate, 5 bromo-4-chloro-3-indolyl glucuronide (X-gluc) were performed with 1 mM substrate in 50mM NaH 2PO4 gH 7.0 at 370C for times from 20 minutes to several hours. After staining, sections were rinsed in 70% ethanol for 5 minutes, then mounted for microscopy.
Cleavage of napthol ASRI glucuronide releases the very insoluble free napthol ASRI which is either simultaneously coupled, or post-coupled with a diazo dye to give a coloured product at the site of enzyme activity. Post couplinq is preferred, as it seems to qive a much lower background. Sections were incubated in 0.1 m 4aP04 pH 7.0 with 1 mM Napthol ASBI glucuronide in a moist chamber at 370C for 15 minutes to 3 hours. The specimen is then washed in phosphate buffer and coupled using a fresh solution of diazotised dye in phosphate buffer.Postcoupling with a 1-3 mg/ml solution of Fast Garnet C.nS in phosphate buffer, pH 7, gives a very nice result after as little as thirty seconds coupling, after which the section is washed and mounted for light microscopy.
Fixation conditions will vary with the tissue, and its permeability to the fixative. Glutaraldehyde does not easily penetrate leaf cuticle, but works well with stem cross sections. Fixation with 2.5E qlutaraldehyde in 0.1 M NaPfl sH 7.0 for 2-3 minutes on ice leaves a reasonable
4 amount of GUS activity, when followed by extensive washing. 3% formaldehyde in 50 mN NaPO4 pH 7.0 for 30 minutes un ice also works well, and penetrates leaf cuticle, leaving high GUS activity. It is recommended that fixation is tested empirically in any new system.
Purification of beta-glucuronidase Peta-glucuronidase was purified essentially as described from E. coli cells containing the plasmid pRAJ210 which contains the entire beta-glucuronidase coding region and promoter/operator. Fight liters of cells were grown in L broth with 50 ug/ml ampicillin at 370C with vigorous agitation. The cells were harvested as they approached saturation, washed in M9 salts, and resuspended in about 100 ml of 100 mM NaPO4 pH 7.0 10 mM beta-mercaptoethanol, 50 mM NaCL, 0.2% Triton X-100 and 25 ug/ml phenylmethyl sulphonyl fluoride. The slurry was passed through a
French pressure cell at 12,000 psi, and the resultant lysate was stirred on ice for 30 minutes.The lysate was spun at 10,000 x q for 30 minutes at 40C, and the turbid supernatant was dialysed overnight against several changes of 50 mM Tris pH 7.6, 10 mM B-ME (buffer A). The dialysate was loaded onto a column of DEAE Sephacel (2.5 x 40 cm) equilibrated in the same buffer, at 4 C. The column was washed with loading buffer and eluted with a 500 ml linear gradient of NaC1 (O - 0.4 M). The combined peak fractions were concentrated in an Amicon ultrafiltration apparatus with a PM 30 membrane to a final volume of 27 ml. This volume was loaded onto a 500 ml (2.5 x 100 cm) Sephacryl S-200 gel filtration column, and eluted with buffer A plus 100 mM NaC1. Peak fractions were pooled and dialysed overnight against 20 mM NaOAc pH 5.0, at 40C.A precipitate formed that was collected by centrifugation at 5000 x q for 20 minutes at 40C. The resulting pellet was dissolved in buffer A, and both pellet and supernatant were assayed for beta-glucuronidase activity and analysed by SDS-PAGE. The supernatant contained the majority of the activity, and by gel analysis had lost nearly all of the contaminating protein, (greater than 95% purity as judged by Coomassie staining) obviating further chromatograpy. The purified enzyme was stored in GUS extraction buffer at 40C. The final yield was about 350 mg.
Results
Higher Plants contain no detectable beta-glucuronidase activity
Roots, stems and Jeaves were taken from wheat, tobacco, tomato, putatu, Brassica napus and Arabidopsis thaliana, potato tubers and seed from wheat and tobacco were homogenised with GUS extraction buffer containing a variety uf orutease inhibitors such as PMSF and leupeptin.
The plant extracts were incubated in a standard assay at 370C for 4 to i6 hours, and the fluorescence of MU was measured. Endogenous activity was below the limits of detection. Extremely lengthy assays occasionaly gave low levels of PIU fluorescence, but the kinetics of MU accumulation were consistent with a slow conversion of the slucuronide into another form, possibly a glucose, that was subsequently cleaved by intrinsic qlycosidases. Betagalactosidase assays performed under similar conditions on tobacco and potato extracts were off-scale (at least 10,000 times higher than the minimal detectable signal) within 30 minutes. Reconstruction experiments were performed with purified GUS added to tobacco and potato extracts to demonstrate the ability of these extracts to support beta-glucuronidase activity (data not shown).
Construction of plasmids for transformation of plants with
GUS fusions
A general purpose vector for constructing gene fusions was made by ligating the coding region of GUS 5' of the opaline synthase sulyadenylation site (see reference 12) in the polylinker sites of pBIN 19 (see reference 45).
This vector, pBI101 (see Figure 9) contains unique restriction sites for Hind III, Sal I, Xba I, BamH I, and
Sma I upstream of the AUG initiator codon of GUS, to which promoter DNA fragments can be conveniently ligated. The cauliflower mosaic virus 35S promoter (see reference 50) as described in the expression vector pROK1 (see reference 51) was ligated into the Hind III and BamH I sites to create pBI121. Similarly the promoter from a tobacco gene encoding the small subunit of ribulosebisphosphate carboxylase small, Ntss23 (see reference 52) deleted of rbcS coding sequences was fused to pBI101 to make pBI131.
Figure 9 illustrates the structure of the expression vectors.
The lower portion of Figure 9 shows the T-DNA region of pBI1101, containing polylinker cloning sites upstream of the beta-glucuronidase gene, followed by the nopaline synthase solyadenylation site (NOS-ter). Pst I and Sph I are not unique to the polylinker. The expression cassette is within pBIN 19, giving pBIl0l a total length of approximately 12 kb.
The middle portion of Figure 9 shows chimaeric CaMV 35S
GUS gene in pRI121. An 800 bp Hind III - BamH I CaMV 35S promotor fragment (see reference 59) was ligated into the corressondinq sites of pBIl0l. The mRNA initation site is approximately 20 bp 5' of the GUS initiator codon.
The top portion of Figure 9 shows chimaeric rbcS-GIlS gene in pBI101. A 1020 bp Hind III - Sma 1 fragment containing the promoter of a tobacco ribulose bisphosphate caarboxylase small subunit gene (rbcS) was ligated into the corresponding sites of pBI101. The mRNA initiation site is approximately 55 bp 5' of the GUS initiator codon, and contains nearly the entire untranslated leader of the rbcS gene.
Figure 9 also illustrates the differences between the 3 nRI101 nlasmids.
Chimaeric GIS genes are expressed in transformed plants
Nicotiana tabacum var. Samsun plants were transformed with Agrobacterium binary vectors (see reference 45) containing transcriptional fusions of either the CaMV 35S promotur or the tobacco rbcS promotor with the coding region of GUS as shown in Figure 9. Several kanamycin resistant plants were regenerated from each transformation.
Two rbcS-GS transformants and two CaMV-GUS transformants were chosen for further study. First assays were made of various organs of one plant from each transformation, axenically cultured ir 3000 lux white light, 18 hour day, 6 hour night. Extracts were prepared from axenic tobacco nlants using about 50 mg fresh weight of tissue ground in 500 ul extraction buffer. 5 ul of extract was assayed as described in Materials and Methods" above. Mature leaves were lower, expanded leaves approximately 80 mm long, while young leaves were approximately 5 mm long, and were dissected from the shoot apex. All samples were taken from the same plant (either CaMV-GUS 21, rbcS GUS 2 o non-transformed) at the same time.Leaf tissue was taken from a non-transformed plant for this assay, although all organs showed no GUS activity (date not shown).
The results of this analysis are shown in Figure 10, and
tabulated in Table 1 using either of two normalisation methods (see following discussion).
The rate data shown in Figure 10 were converted to
specific activity by measuring the protein concentration of the extracts using the Rradford reagent. The data are
also presented as GUS activity per unit weight of DNA in
the extract to better account for the differences in cell number between different tissues.
The plant containing a rcbS-GUS fusion (rbcS-GUS 2) exhibited a pattern of gene expression consistent with earlier studies using heterologous rbcS gene fusions (see reference 53). The highest specific activity, using either protein or DNA as a denominator, was found in older leaves (about 8cm long), with progressively less activity
in very young leaves (less than 5 mm), stems and roots.
The other rbcS-GUS fusion plant showed a similar pattern
(data not shown).
The two plants transformed with the CaMV 35S-GUS fusion displayed a pattern of gene expression distinct from that of the rbcS-GUS fusion plants. The highest levels of activity were found in roots, with similar levels in stems. GUS activity was also high in leaves, cunsistent with previous observations that the CaMV 35S promoter is expressed in all plant organs (see reference 50).
To verify that no significant rearrangements of the transforming DNA had occurred, a Southern blot analysis was conducted as shown in Figure 11, which is an autoradiograph of a Southern blot of DNA extracted from transformed plants and digested with restriction 32 endonucleases. The filter was hybridised with a 32p labelled restriction fragment containing the coding region of the beta-glucuronidase gene. In this Figure
Lane 1. CaMV-GUS 21 EcoR I
Lane 2. CaMV-GUS 21 EcoR I & Hind III
Lane 3. CaMV-GUS 29 EcoR I
Lane 4. CaMV-GUS 29 EcoR I & Hind III
Lane 5. rbcS-GUS 2 EcoR I
Lane 6. rbcS-GUS 2 EcoR I & Hind III
Lane 7. rhcS-GUS 5 EcoR I
Lane 8. rhcs-GUS 5 EcoR I & Hind III
Lane 9. Non-transformed EcoR I
Lane 10. Non-transformed EcoR & Hind III
Lane 11. Single copy reconstruction of GUS coding region
Lane 12.Five copy reconstruction.
Digestion of DNA extracted from all of the transformants with Hind III and EcoRI released a single internal fragment of T-DNA consisting of the nopaline synthase polyadenylation site, the GUS coding region and the promoter (CaMV35S or rbcS). RbcS-GUS transformants contained 3 copies (rbcS-GUS2, Figure 11, lane 6) and about 7 copies (rbcS-GUS5, lane 8) of the predicted 3.1 kb
Hind III - EcoR 1 fragment. Diqestion with EcoRI revealed multiple border fragments (Figure 11, lanes 5 and 7) confirmina the copy number estimates deduced from the double digestions. Similarly CaMV 35S-GUS slants had multiple insertions as shown in Figure 11 lanes 1 to 4.
Ca81V-C,US 21 had 3 copies of the nredicted 2.9 kh fragment, while CaMV-GU529 had 2 copies. No hybridisation of the labelled GUS coding region to untransformed plant tissue was observed (lanes 9 and 10).
Visualisation of GtS activitv on SDS-polyacrylamide aels Extracts of transformed plants were prepared and electrophoresed, together with negative controls and varying amounts of purified beta-glucuronidase, on an SDSpolyacrylamide gel. The gel was rinsed to reduce the SDS concentration, and then treated with the fluorogenic susbstrate, MUG. After the reaction has proqressed sufficiently, the gel was made alkaline to enhance fluorescence, placed on a long wave UV box and photographed (Figure 12). The gel was trans-illuminated with 365 nm light and photographed using a Kodak Wratten 2E filter. In Figure 12,
Lane 1. Transformed plant extract - CAB-GUS fusion
Lane 2.Transformed plant extract - SSU-GUS 2
Lane 3. Transformed plant extract - CaMV-GUS 21
Lane 4. tlon-transformed plant extract
Lane 5. ìNün-transformed plant extract plus 1 ng GUS
Lane 6. Non-transformed plant extract plus 10 ng GUS
Lane 7. Non-transformed plant extract plug 50 nq GUS.
GUS activity can be seen in all lanes containing purified enzyme, with a limit of sensitivity in this experiment of one nanogram. In other experiments, we have observed activity with as little as 0.2 ng has been observed. The lanes containing the SSU-GUS and CaMV-GUS fusion extracts show GUS activity that migrates with the same mobility as the purified enzyme, indicating that translation is initiating and terminating at the correct locations in the
GUS sequence and tht no significant post-translational processing is occurring. An additional lane was included that contained a protein fusion between part of the tobacco chlorophyll a/h binding protein and GUS that shows decreased mubility relative to purified beta glucuronidase, as predicted.Staining of gels using the histochemical methods described below proved to be effective, but not as sensitive as the fluorogenic stain
(data not shown).
GUS activity in plants can be visualised using histochemical methods
Although there are very few organs in plants, each organ is composed of many different cell types, often associated in the form of distinct tissues. Since different organs consist of unequal combinations uf these cell types intermingled in a highly complex fashion, the meaningful interpretation of "organ-specific" gene expression becomes a difficult exercise. One approach to characterising cell-type specific expression of chimeric genes in plants has utilised microdisseetion (see reference 54). These methods are, however, extremely laborious, prone to varying degrees of contamination, and many cel-types within plants are inaccessible to the techniques.
Alternatively, localisation of chimeric gene activity by histochemical methods has been successful in other systems (see eg reference 2).
To determine whether it would be possible to use histochemistry to investigate single-cell or tissuespecific expression of GUS gene fusions in plants, nreliminary experiments were carried out on sections of stems of several independently transformed rbcS-GUS and CaNV-GUS plants. Stem sections were chosen both for their ease of manipulation and because most of the cell types of a mature plant are represented in stem. To illustrate the liqht-requlated nature uf the rbcS-GUS fusion, the plants were illuminated from one side only for one week before sectioning. Sections from both nlants stained intensely with the substrate while non-transformed tissue did not stain.Stem sections of CaMV-GUS plants always show highest levels of activity in phloem tissues along the inside and outside of the vascular ring, most prominently in a punctate pattern that overlies the internal phloem and in the rays of the phloem parenchyma which join the internal and external phloem (see reference 55). There is also variable lighter staining throughout the parenchymal cells in the cortex and in the pith, and also in epidermal cells, including the trichomes.
RbcS-GUS stem sections rarely if ever show intense staining in the trichomes, epidermis, vascular cells or pith, but tend to stain most intensely over the cortical parenchyma cells containing chloroplasts (chlorenchyma), with faint and variable staining in the pith. Although the strongest staining is most often seen in a symmetrical ring around the vascular tissue just inside the epidermis, an asymmetric distribution of staining in the cortical stem cells is sometimes observed. Suspecting that this pattern was due to uneven lighting, a plant was illuminated from one side for one week before sectioning, and it was found that the staining was asymmetric, with intense staining in the chloroplast-containing cells proximal to the light source.The staining Datterns observed for both the CaMV 35S-GUS and the rbcS-GUS transformants are consistent between several independent transformants. Untransformed plants never show staining with X-Gluc, even after extending assays of several days.
DISCUSSION
New methods are provided for analysing gene exnression in transformed slants that are potentially of general utility. The beta-glucuronidase gene from E. coli has been expressed at high levels in transformed tobacco plants with no obvious ill effects on plant gruwth or reproduction. The ability to quantitate gene expression through the routine use of enzyme kinetics greatly enhances the precision and resolution of the question that can be asked. It should he emphasised that the determination of rates of enzyme activity eliminates the vagaries inherent in CAT, NPTII and luciferase assays, and allows accurate determination of quantity of chimacric gene oroduction, even over an intrinsically fluorescent bakground.The fluorometric assay is very specific, extremely sensitive, inexpensive and rapid. Minute quantities of tissue can be assayed with confidence, recently GUS levels have been measured in isolated single cells of transtormed plants.
Beta-glucuronidase is very stable in extracts and in cells, with a half-life in living mesophyll protoplasts of about 50 hours. Because of this, it is felt reasonable to interpret GUS levels as indicative of the integral of transcription and translation, rather than the rate. In addition, GUS is not completely inactivated by SDS-PAGF, can tolerate large amino-terminal fusions without loss of enzyme activity and can be transported across chloroplast membranes with high efficiency. It is felt, therefore, that the system will also be very useful in studying the transnort and targeting of proteins, not only in plants, but in other systems that lack intrinsic betaglucuronidase activity, such as Saccharomyces cerevisiae and Drosophila melanogaster.
A commercially available histochemical substrate has been used to demonstrate GUS activity in transformed slant tissue. Other substrates are available and give excellent results. It is emphasised that meaningful interpretation of results of histological analysis in terms of extent of chimaeric gene activity, whether by in situ bybridisation methods or by histochemistry, as presented here, is not a trivial or straightforward matter. There are numerous variables that must be dealt with (reviewed in reference 18). However, with these cautions, histochemical methods can be very powerful for resolving differences in gene expression between individual cells and cell-types within tissue.
A distinctly non-uniform distribution of GUS activity in stem sections of several CalV-GUS transformed plants has been observed. Different cell-types within plants are expected to have differing metabolic activity with corresponding differences in rates of transcription and translation, and our results may reflect such a difference. Alternatively, since many of the cells of the phloem have very small cruss-sectiona1 areas, the intense dye deposition seen in these regions may simply reflect the greater cell number per unit area. The localisation that is observed may also be due to a real difference in the level of expression of the CaMV 35S promoter between cell types.Recently, Naata et al (see reference 62) have argued that the CaMV 35S promoter is preferentially active in cells during the S phase of the cell cycle. If this is true, then the pattern of GUS staining observed may reflect cell division activity in these cells. This observation is consistent with the proposed role of the 35S transcript of CaMV in viral replication (reference 63). It is also interesting that the other class of plant
DNA viruses, the geminiviruses, replicates in the phloem sarenchyma (reference 64). It is concluded therefore that it is nu longer adequate to describe the 35S promoter as "constitutive" solely by the criteria of expression in all plant organs, when there may be a strong dependence of transcription on cell-type or cell cycle.
The distribution of GUS activity in the stem sections of plants transformed with rbcS-GUS genes is consistent with data that indicate a requirement for mature chloroplasts for maximal transcription of chimaeric rbcS genes (see eq reference 54!. Cortical parenchymal cells in the stem contain varying numbers of chloroplasts, while those in the pith and epidermis of the stem rarely contain chlorolasts.
Different cell-types present in each organ contribute differenrly ly to the patterns of gene expression, and each organ consists of different proportions of these celltypes. It has been undertaken to minimise this effect un quantitative analysis oft extracts by suitable choice of a denominator. The parameter that needs to be studied with gene fusions is most often the expression of the gene fusion in each cell. When preparing homogenates from plant organs, the number of cells that contribute to the extract will vary, as will the protein content of each cell and cell-type.The DNA content of the extract will reflect the number of cells that were lysed (see reference 58) whereas the traditional denominator, protein concentration, will nut. vor example, a single leaf mesophyll cell contains much more protein than a single epidermal cell or root cortical cell. However, each will have the same nucleus with the same potential to express the integrated gene fusion.
rising this approach, it is found that the differential expression of the rbcS-GUS fusion is much more pronounced between immature and mature leaf when GUS activity is expressed, per mg of DNA (see Table 1). When protein concentration is used as a denominator, the massive induction of GUS activity during leaf maturation is masked by the concomitant induction of proteins involved in photosynthesis.
The observation that the specific activity of GUS produced by CaMV-GUS fusions is the same in immature and mature leaves when expressed using a protein denominator indicates that the rate of GUS accumulation closely follows the rate of net protein accumulation. The twofold difference in GUS specific activity using a DNA denominator illustrates the accumulation of GUS per cell over time. This quantitative analysis, together with histochemical data, may indicate that the differences between GUS activity in the leaf, stem and root of CahlV- GUS fusion plants could reflect the larger proportion of phleom-associated cells in roots and stems compared to leaves. It is felt that the choice of a DNA denominator best reflects the expression per cell, and hence is a more accurate reflection of the true regulation of the gene.
Prospects of further development of the GUS system
There are many important questions arising from the use of currently available gene-transfer techniques in plants that can be addressed with this new technology. Both
Agrobacterium-mediated transformation and direct nNA uptake methods result in cells and plants transformed with varying numbers of integrated conies of the foreign DNA and with different sites of integration, resulting in plants expressing different amounts of chimacric gene product (see eg references 65 and 66). Previously, analysis of gene expression in transformed plants has been sufficiently laborious to preclude quantitative assays of the large numbers of plants necessary to finaly delineate the contributions of local integration site and copy number to the expression of transformed genes.Using the methods described here, it will be feasible to quantitate the variation that is often ascribed to differing sites and cosy numbers of integrations, and obtain statistically siqnificant answers tu these questions.
The availahility of routine histochemical analysis will greatly facilitate studies of the mechanism of transformation both by Agrobacterium and by direct DNA methods, as well as permitting a more detailed study of developmental regulation. These methods will also allow very rapid and sensitive screening of transformed cells d tissues. Using the indigogenic substrate X-Gluc, GUS activity from single cells and small cell clusters from susnension cultures can he easily resolved.
GUS assay systems lend themselves very well to automation.
The existing spectrophotometric and fluoroqenic assays, and new assays using fluoroqenic substrates that fluoresce maximally at neutral pH will allow the use of automatic microtitre plate analysis of very large numbers of samples. The activity of GUS in lysed single cells can he measured with accuracy; using new fluorogenic substrates, an analysis of GUS expression in single cells of transformed nlants using the fluorescence activated cell sorter is being conducted.
The GtlS fusion system has also been used successfully to monitor the transient expression of chimacric genes introduced into plant cells via electroporation and/o polyethylene glycol treatment. The sensitivity is found to be very high, allowing expression to be reliably measured from a very small number of cells.
Recause of the lack of intrinsic beta-glucuronidase activity in all plants thus far assayed, and because the synthesis of beta-glucuronides can be relatively straightforward, the use of the GUS system to begin "fusion genetics" is being pursued. Due to the complex genomes and long generation times of higher plants, fine scale genetic analysis of complex processes is unfeasible by convention means. However, by using the GUS system and novel substrates, it may be possible to generate positive and negative selections for GUS activity, thereby selecting mutations in the activity of gene fusions, both in planta and in tissue culture.
Table 1
GUS Specific Activity
(pmoles 4-MU/min/mg protein) (pmoles 4-MU/min/mg DNA) Gene Fusion: CaMV 35S-GUS rbcS-GUS untransformed CaMV 35S-GUS rbcS-GUS Plant organ Leaf (5 mm) 283 205 < 0.! 2,530 4,400 Leaf (70 mm) 321 1,523 < 0.1 5,690 93,950 Stem 427 260 < 0.1 13,510 2,650 Root 577 62 < 0.1 12,590 690 References 1. Cox, G.N., and Hirsh, D. (1985) Mol. Cell. Biol. 5, 363-372.
2. Lis, J.T., Simon. J.A.,and Sutton, C.A. (1984) Cell 35, 403-410.
3. Beckwith, R.R. and Zipser, D. eds. (1970) The Lactose
Operon (Cold Spring Harbor Laboratory, Cold Spring Harbor,
New York).
4. Depieker, A., Stachel, S., Dhaese, P., Zambryski, P.
and Goodman H. (1982) J. Molec. Applied Genetics 1, 561575 5. Bevan, M., Barnes, W. and Chilton, M-D (1983) Nucl.
Acids. Res. 11, 369-385.
6. DeGree, H., Dhaese, P., Seurinck, J., Lemmers, M.,
Van Montagu, M., and Schell J., (1982) J. Mol. Applied
Genetics. 1, 499-513.
7. Otter L.A.M.B. and Schilperoot, R.S. (1978) Biochem.
Biopys. Res. Commun. 527, 497-500.
8. Jones, J.D.G., Dunsmuir, P. and Bedbrook, J. (1985)
EMBO J. 4, 2411-2418.
9. Shaw, C.H., Sanders, D.M., Bates, M.R. and Shaw C.H.
(1986) Nucl. Acids. Res. 14, 6603-6613.
10. Herrera-Estrella, L., Depicker.A. , Vanontaqu, M. and
Schell, J. (1983) Nature 303, 209-213.
11. Herrera-Estrella, L., De Block, M.N., Messens, E.,
Hernalsteens, J.P., van Montagu, M. and Schell J.H (1983)
EMBO J. 2, 987-995.
12. 9evan. M.W., Flavell, R.R. and Chilton M-D. (1983)
Nature 304, 184-187.
13. Fraley, R.T., Rogers, S.G., Horsch, R.B., Saunders,
P.S., Flick, J.S., Adams, S.P. Bitter, M.L., Brand,
L.A., Fink, C.L., Fry, J.S., Galluppi, G.R., Güldberg, S.B.. Hoffmann, N.L. and Woo, S.C (1983) roc. Natl, Acad,
Sci USA. 80, 4803-4807.
14. Van den Broeck, G., Timko, M., ausch, A.P., Cashmere,
A.R. , van Montagu, M. and herrera-Estrella, . (1985)
Nature 313, 358-363.
15. Gorman, C.M., Moffatt, L.F., and Howard, B.H., (1982)
Mol, Cell. Biol. 2, 1044.
16. Reiss, B., Sprengel, R., Will, H., and Schaller, H., (1984) Gene 30, 217-223.
17. Paigen, K. (1979) Ann. Rev. Genet. 13, 417-466.
18. Pearse, A.G.F. (1972) Histochemistry: Theoretical and
Applied Third Edition, Vol II, pp 808-840 (Churchill
Livingstone, Edinburgh).
19. Novel, G. , and Novel, M. (1973) Mol. Gen. Genet. 120, 319-335.
20. Novel, G., Didier-Fichet, M.L., and Stueber, F.
(1974)J. Baceriol. 120, 89-95.
21. Novel, M., and Novel, G. (1976) J. Bacteriol. 127, 406-417.
22. Novel, M., and Novel, G. (1976) J. Bacteriol. 127, 418-432.
25. Birnboim, H.C. and Doly, J. (1979) Mucleic Acids Res.
7, 1513.
26. Maniatis, T., Fritsch, E.F. and Sambrook, J., eds.
(1982) Molecular Clowning: A Laboratory Manual. (Cold
Spring Harbor Laboratory, Cold Spring Harbor, New York).
27. Dretzen, G., Bellare, M., Sasson-Corsi, P., and
Chambon, P. (1981) Anal. Biochem. 112, 295-298.
28. Sanger, F. and Coulson, A.R. (1975) J. Mol. Biol. 95, 443.
29. Biggin, M.D., Gibson, R.J., and Hong, G.F. (1983)
Proc. Natl, Acad, Sci, USA 80, 3963-3965.
30. Zoller, M.J., and Smith, M. (1982) Nucleic Acids Res.
10, 6487-6500.
31. Vieira, J. and Messing, J. (1982) Gene 19, 259-268.
32. Dente, L., Cesarini, G. and Cortese, R. (1983) Nucleic
Acids Res. 11, 1645.
33. Bradford, M. (1976) Anal. Biochem. 72, 248.
34. Laemmli, U.K. (1970) Nature 227, 680.
35. Kozak, M. (1983) Microbiol. Rev. 47, 1-45.
36. Stoeber, F. (1961) These de Docteur es Sciences,
Paris 37. Kramer, J.M., Cox, G.N., & Hirsh, D., (1982) Cell, 30 599-606.
38. Kramer J.M., Cox, G.N., & Hirsh, D., (1985) J. Biol.
Chem, 260, 1945-1951.
39. Klass, M., Kindsley, S., and Lopez, L., ( (1984) Mol.
well. Bill. 4, 529-537.
40. Klass, M.R., and Hirsh, D., (1982) Develom Biol. 84, 299-312.
41. Stinchcomb, D., Shaw, J., Carr, S.H., and Hirsh, D., (1985), Mol. Cell. Biol, 5, 3484-3496.
42. Sebastiano, M., D'Allessio, M., and Bazzicalupo, P., (1986), Genetics, 112, 459-468.
43. Fishman, W.H., and Goldman, S.S., (1965), 3.
Histochem, Cytochem, 13, 441-447.
44. Fire, A., (1986), EMBO J. In the press.
45. Bevan, M.W., (1984) Nucl, Acids Res. 12, 8711-8721.
46. Horch, R.B., Fraley, R.T., Rowers, S.G., Sanders,
P.R., Lloyd, A., and Hoffmann, N., (1984) Science, 223, 496-498.
47. Marashige, T., and Skoog, F., (1962), Physiol. Plant, 15, 473.
48. Guilbault, G., (1973) "Practical Fluorescence:
Theory, Methods and Techniques" Dekker, New York.
49. O'Brien, T.P., and McCully, M.E., (1981) "The Study of
Plant Structure: Principles and Selected Methods"
Termarcarphi Pty. Ltd, Melbourne, Australia.
50. O'Dell, J.T., Nagy, F., and Chua, N-H. (1985) Nature 313, 810-812.
51. Baulcombe, D.C., Saunders, G.R., Bevan, M.W., Mayo,
M.A., and Harrison, B.D., (1986) Nature 321, 446-449.
52. Mazur, B.J., and Chui, C-F. (1985) Nucl. Acids Res.
13, 2373-2386.
53. Simpson, J., Van Montagu, M., and Herrera-Estrella,
L., (1986) Science 233, 34-38.
54. Simpson, J., Schell, J., Van Montagu, M., and Herrera
Estrella, L., (1986) Nature 323, 551-554.
55. Esau, K., (1977) The Anatomy of Seed Plants, Wiley,
New York.
56. Mones, D.S. and Quigley, M. (1981) Anal. Biochem.
114, 193-201.
57. Feinberg, A.P. and Vogelstein, B. (1984) Anal.
Biochem. 137, 266-267.
58. Labarca, C. and Paigen, K. (1980) Anal. Biochem. 102, 344-352.
59. Guilley, H., Dudley, R.K., Jonard, G., Balazs, E. and
Richards R.E. (1982) Cell 30, 763-773.
60. Ow, D.W., Wood, K.V., DeLuca, M., DeWet, J.R.,
Helsinki, D.R. and Howell, S.H. (1986) Science 234, 856859.
61. DeLuca, M., and McElroy, W.D. (1978) Methods in
Enzymology 57, 3-15.
62. Nagata, T., Okada, K., Kawazu, T. and Takebe, I.
(1987) Mol. Gen. Genet. 207, 242-244.
63. Pfeiffer, P. and Hohn, T. (1983) Cell 33, 781-790.
64. Kim, K.S., Shock, T.C. and Goodman, R.M. (1978)
Virology 89, 22-23.
65. Jorgensen, R.A. Snyder, C. and Jones, J.D.G. (1987)
Mol. Gen. Genet. 207, 471-477.
66. Jones J.D.G., Gilbert, D.E., Grady, K.L. and Jorgensen
R.A. (1987) Mol. Gen. Genet. 207, 478-488.
Claims (18)
1. A gene fusion product comprising a gene coding for beta-glucuronidase (GUS).
2. A gene fusion product according to claim 1, comprising the uidA gene of E. coli.
3. A gene fusion product according to claim 1 or 2, wherein the gene coding for GUS is under control of the E.
coli lacZ promoter.
4. A gene fusion product according to claim 1 or 2, comprising the cauliflower mosaic virus (CaMV) 35S promoter.
5. A gene fusion product according to claim 1 or 2, comprising the promoter from the small subunit of ribulose bisphosphate carboxylase (rbcS).
6. A gene fusion product according to any one of the preceding claims, further comprising a gene of interest.
7. A plasmid comprising a gene coding for GUS.
8. A plasmid according to claim 7, constructed from plasmid pBINl9.
9. A plasmid according to claim 7 or 8, comprising pBI101.
10. A plasmid according to claim 7, comprising pBI121.
11. A plasmid according to claim 7, comprising pBI131
12. A plasmid according to any one of claims 7 to 11, further comprising a gene of interest.
13. A method of introducing a gene of interest to a host, comprising introducing to the host a gene fusion product comprising a gene coding for GUS and the gene of interest.
14. A method of monitoring expression of a gene of interest in a host, comprising introducing to a host a gene fusion product comprising a gene coding for GUS and the gene of interest, and monitoring to detect the presence of GUS.
15. A method according to claim 14, wherein GUS is assayed using spectrophotometric, fluorometric or histochemical techniques.
16. A method according to claim 13, 14, or 15 wherein the host comprises a plant, animal, yeast or other microorganism.
17. A transformed host to which has been introduced a gene fusion product comprising a gene coding for GUS.
18. A product of the transformed host of claim 17.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB8626862A GB8626862D0 (en) | 1986-11-11 | 1986-11-11 | Gene fusion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| GB8725852D0 GB8725852D0 (en) | 1987-12-09 |
| GB2197653A true GB2197653A (en) | 1988-05-25 |
| GB2197653B GB2197653B (en) | 1991-04-24 |
Family
ID=10607112
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8626862A Pending GB8626862D0 (en) | 1986-11-11 | 1986-11-11 | Gene fusion |
| GB8725852A Expired GB2197653B (en) | 1986-11-11 | 1987-11-04 | Chimeric genes |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB8626862A Pending GB8626862D0 (en) | 1986-11-11 | 1986-11-11 | Gene fusion |
Country Status (1)
| Country | Link |
|---|---|
| GB (2) | GB8626862D0 (en) |
Cited By (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989003880A1 (en) * | 1987-10-29 | 1989-05-05 | Richard Anthony Jefferson | A gene coding for glucuronide permease |
| WO1991018986A1 (en) * | 1990-05-25 | 1991-12-12 | Luminis Pty. Ltd. | Marker for yeast strain identification |
| AU620827B2 (en) * | 1987-10-29 | 1992-02-27 | Cambia Biosystems Llc | A gene coding for glucuronide permease |
| WO1993018149A1 (en) * | 1992-03-03 | 1993-09-16 | Pioneer Hi-Bred International, Inc. | Self-incompatibility alleles of brassica |
| US5418132A (en) * | 1992-06-18 | 1995-05-23 | Washington University | Genetically engineered cell line for detecting infectious herpes simplex virus and method therefore |
| US5503998A (en) * | 1990-02-26 | 1996-04-02 | Agracetus, Inc. | Plant transformation process with early identification of germ line transformation events |
| US5614395A (en) * | 1988-03-08 | 1997-03-25 | Ciba-Geigy Corporation | Chemically regulatable and anti-pathogenic DNA sequences and uses thereof |
| US5733720A (en) * | 1992-06-18 | 1998-03-31 | Washington University | Genetically engineered cell lines for detecting infectious herpesvirus and methods therefor |
| US5789214A (en) * | 1988-03-08 | 1998-08-04 | Novartis Finance Corporation | Method of inducing gene transcription in a plant |
| WO1998010074A3 (en) * | 1996-09-04 | 1998-08-20 | Basf Ag | Adenylosuccinate synthetase |
| US5851766A (en) * | 1995-05-31 | 1998-12-22 | Novartis Finance Corporation | Process for isolating chemically regulatable DNA sequences |
| EP0896063A2 (en) | 1991-08-28 | 1999-02-10 | Novartis AG | Method for the selection of genetically transformed cells and compounds for use in the method |
| US5958676A (en) * | 1992-06-18 | 1999-09-28 | Washington University | Genetically engineered cell lines for detecting infectious herpesvirus and methods therefor |
| WO2000055333A1 (en) * | 1999-03-17 | 2000-09-21 | Center For The Application Of Molecular Biology To International Agriculture | MICROBIAL β-GLUCURONIDASE GENES, GENE PRODUCTS AND USES THEREOF |
| WO2002036787A2 (en) | 2000-10-30 | 2002-05-10 | Bayer Cropscience S.A. | Herbicide-tolerant plants through bypassing metabolic pathway |
| US6391547B1 (en) | 1997-09-09 | 2002-05-21 | Center For The Application Of Molecular Biology To International Agriculture | Microbial β-glucuronidase genes, gene products and uses thereof |
| US7087420B1 (en) | 1997-07-17 | 2006-08-08 | Cambia | Microbial β-glucuronidase genes, gene products and uses thereof |
| US7169968B2 (en) | 2000-12-22 | 2007-01-30 | Biogemma Uk Limited | Elongase promoters |
| US7459607B2 (en) | 2001-10-12 | 2008-12-02 | Biogemma Uk Limited | Oil biosynthesis |
| WO2011161466A1 (en) | 2010-06-25 | 2011-12-29 | The University Of Warwick | Plant eukaryotic translation initiation factor 4e |
| WO2012038717A1 (en) | 2010-09-22 | 2012-03-29 | Advanced Technologies (Cambridge) Limited | Transgenic plants |
| WO2013140155A1 (en) | 2012-03-20 | 2013-09-26 | British Americal Tobacco (Investments) Limited | Transgenic plants with altered nitrate levels in leaves |
| WO2013140154A1 (en) | 2012-03-20 | 2013-09-26 | British American Tobacco (Investments) Limited | Transgenic plants having lower nitrate content in leaves |
| WO2013140157A1 (en) | 2012-03-20 | 2013-09-26 | British American Tobacco (Investments) Limited | Transgenic plants with altered nitrate levels in leaves |
| US8716558B2 (en) | 1999-06-30 | 2014-05-06 | Marker Gene Technologies, Inc. | Method of altering glycosylation of proteins in response to nojirimycin glucuronide in a plant cell expressing glucuronidase |
| WO2014087159A1 (en) | 2012-12-05 | 2014-06-12 | British American Tobacco (Investments) Limited | Transgenic plants having altered lignin density |
| US9260720B2 (en) | 2009-02-27 | 2016-02-16 | British American Tobacco (Investments) Limited | Transgenic plants comprising constructs encoding phosphoenolpyruvate carboxykinase and/or pyruvate orthophosphate dikinase |
| WO2018148169A1 (en) | 2017-02-07 | 2018-08-16 | University Of Kentucky Research Foundation | Method |
| WO2018237107A1 (en) | 2017-06-23 | 2018-12-27 | University Of Kentucky Research Foundation | Method |
| WO2021205000A2 (en) | 2020-04-09 | 2021-10-14 | R.J. Reynolds Tobacco Company | Method |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0234075A1 (en) * | 1984-12-26 | 1987-09-02 | Repligen Corporation | Prokaryotic expression system |
| EP0235410A1 (en) * | 1984-12-26 | 1987-09-09 | Repligen Corporation | Prokaryotic expression system |
-
1986
- 1986-11-11 GB GB8626862A patent/GB8626862D0/en active Pending
-
1987
- 1987-11-04 GB GB8725852A patent/GB2197653B/en not_active Expired
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0234075A1 (en) * | 1984-12-26 | 1987-09-02 | Repligen Corporation | Prokaryotic expression system |
| EP0235410A1 (en) * | 1984-12-26 | 1987-09-09 | Repligen Corporation | Prokaryotic expression system |
Non-Patent Citations (3)
| Title |
|---|
| BIOCHEMISTRY SOCIETY TRANSACTIONS 1987 VOL 15 NO PAGES 17-18 * |
| JOURNAL OF MOLECULAR BIOLOGY 1987 VOL 193 NO 1 PAGES 41-46 * |
| PROCEEDINGS OF THE NATIONAL ACADEMYY OF SCIENCES (USA) 1987 VOL 83 NO 22 PAGES 8447-8451 * |
Cited By (52)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1989003880A1 (en) * | 1987-10-29 | 1989-05-05 | Richard Anthony Jefferson | A gene coding for glucuronide permease |
| AU620827B2 (en) * | 1987-10-29 | 1992-02-27 | Cambia Biosystems Llc | A gene coding for glucuronide permease |
| GB2229184B (en) * | 1987-10-29 | 1992-01-22 | Richard Anthony Jefferson | A gene coding for glucuronide permease |
| GB2229184A (en) * | 1987-10-29 | 1990-09-19 | Richard Anthony Jefferson | A gene coding for glucuronide permease |
| US5767369A (en) * | 1988-03-08 | 1998-06-16 | Novartis Finance Corporation | DNA sequences encoding SAR8.2 proteins and uses thereof |
| US5689044A (en) * | 1988-03-08 | 1997-11-18 | Novartis Corporation | Chemically inducible promoter of a plant PR-1 gene |
| US5942662A (en) * | 1988-03-08 | 1999-08-24 | Novartis Finance Corporation | Inducible herbicide resistance |
| US5847258A (en) * | 1988-03-08 | 1998-12-08 | Novartis Finance Corporation | DNA encoding β-1,3-glucanases |
| US5650505A (en) * | 1988-03-08 | 1997-07-22 | Novartis Corporation | Chemically regulatable and anti-pathogenic DNA sequences and uses thereof |
| US5654414A (en) * | 1988-03-08 | 1997-08-05 | Novartis Finance Corporation | Chemically inducible promoter of a cucumber chitinase/lysozyme gene |
| US5880328A (en) * | 1988-03-08 | 1999-03-09 | Novartis Finance Corporation | DNA encoding plant chitinases |
| US5789214A (en) * | 1988-03-08 | 1998-08-04 | Novartis Finance Corporation | Method of inducing gene transcription in a plant |
| US5856154A (en) * | 1988-03-08 | 1999-01-05 | Novartis Finance Corporation | Method of protecting plants from oomycete pathogens |
| US5614395A (en) * | 1988-03-08 | 1997-03-25 | Ciba-Geigy Corporation | Chemically regulatable and anti-pathogenic DNA sequences and uses thereof |
| US5777200A (en) * | 1988-03-08 | 1998-07-07 | Novartis Finance Corporation | Chemically regulatable and anti-pathogenic DNA sequences and uses thereof |
| US5503998A (en) * | 1990-02-26 | 1996-04-02 | Agracetus, Inc. | Plant transformation process with early identification of germ line transformation events |
| WO1991018986A1 (en) * | 1990-05-25 | 1991-12-12 | Luminis Pty. Ltd. | Marker for yeast strain identification |
| EP0896063A2 (en) | 1991-08-28 | 1999-02-10 | Novartis AG | Method for the selection of genetically transformed cells and compounds for use in the method |
| WO1993018149A1 (en) * | 1992-03-03 | 1993-09-16 | Pioneer Hi-Bred International, Inc. | Self-incompatibility alleles of brassica |
| US5733720A (en) * | 1992-06-18 | 1998-03-31 | Washington University | Genetically engineered cell lines for detecting infectious herpesvirus and methods therefor |
| US5418132A (en) * | 1992-06-18 | 1995-05-23 | Washington University | Genetically engineered cell line for detecting infectious herpes simplex virus and method therefore |
| US5958676A (en) * | 1992-06-18 | 1999-09-28 | Washington University | Genetically engineered cell lines for detecting infectious herpesvirus and methods therefor |
| US5851766A (en) * | 1995-05-31 | 1998-12-22 | Novartis Finance Corporation | Process for isolating chemically regulatable DNA sequences |
| WO1998010074A3 (en) * | 1996-09-04 | 1998-08-20 | Basf Ag | Adenylosuccinate synthetase |
| US7087420B1 (en) | 1997-07-17 | 2006-08-08 | Cambia | Microbial β-glucuronidase genes, gene products and uses thereof |
| US6641996B1 (en) * | 1997-09-09 | 2003-11-04 | Cambia | Microbial β-glucuronidase genes, gene products and uses thereof |
| US6391547B1 (en) | 1997-09-09 | 2002-05-21 | Center For The Application Of Molecular Biology To International Agriculture | Microbial β-glucuronidase genes, gene products and uses thereof |
| US7176006B2 (en) | 1997-09-09 | 2007-02-13 | Cambia | Microbial β-glucuronidase genes, gene products and uses thereof |
| AU775238B2 (en) * | 1999-03-17 | 2004-07-22 | Cambia | Microbial beta-glucuronidase genes, gene products and uses thereof |
| WO2000055333A1 (en) * | 1999-03-17 | 2000-09-21 | Center For The Application Of Molecular Biology To International Agriculture | MICROBIAL β-GLUCURONIDASE GENES, GENE PRODUCTS AND USES THEREOF |
| US8716558B2 (en) | 1999-06-30 | 2014-05-06 | Marker Gene Technologies, Inc. | Method of altering glycosylation of proteins in response to nojirimycin glucuronide in a plant cell expressing glucuronidase |
| WO2002036787A2 (en) | 2000-10-30 | 2002-05-10 | Bayer Cropscience S.A. | Herbicide-tolerant plants through bypassing metabolic pathway |
| EP2141240A2 (en) | 2000-10-30 | 2010-01-06 | Bayer CropScience SA | Plants that can tolerate herbicides by bypassing the metabolic route |
| US7169968B2 (en) | 2000-12-22 | 2007-01-30 | Biogemma Uk Limited | Elongase promoters |
| US7459607B2 (en) | 2001-10-12 | 2008-12-02 | Biogemma Uk Limited | Oil biosynthesis |
| US9260720B2 (en) | 2009-02-27 | 2016-02-16 | British American Tobacco (Investments) Limited | Transgenic plants comprising constructs encoding phosphoenolpyruvate carboxykinase and/or pyruvate orthophosphate dikinase |
| WO2011161466A1 (en) | 2010-06-25 | 2011-12-29 | The University Of Warwick | Plant eukaryotic translation initiation factor 4e |
| WO2012038717A1 (en) | 2010-09-22 | 2012-03-29 | Advanced Technologies (Cambridge) Limited | Transgenic plants |
| US9322029B2 (en) | 2010-09-22 | 2016-04-26 | British American Tobacco (Investments) Limited | Transgenic plants with reduced nitrate content |
| WO2013140157A1 (en) | 2012-03-20 | 2013-09-26 | British American Tobacco (Investments) Limited | Transgenic plants with altered nitrate levels in leaves |
| WO2013140154A1 (en) | 2012-03-20 | 2013-09-26 | British American Tobacco (Investments) Limited | Transgenic plants having lower nitrate content in leaves |
| WO2013140155A1 (en) | 2012-03-20 | 2013-09-26 | British Americal Tobacco (Investments) Limited | Transgenic plants with altered nitrate levels in leaves |
| US9708622B2 (en) | 2012-03-20 | 2017-07-18 | British American Tobacco (Investments) Limited | Transgenic plants with altered nitrate levels in leaves |
| US10017776B2 (en) | 2012-03-20 | 2018-07-10 | British American Tobacco (Investments) Limited | Transgenic plants with altered nitrate levels in leaves |
| US10597666B2 (en) | 2012-03-20 | 2020-03-24 | British American Tobacco (Investments) Limited | Transgenic plants with altered nitrate levels in leaves |
| WO2014087159A1 (en) | 2012-12-05 | 2014-06-12 | British American Tobacco (Investments) Limited | Transgenic plants having altered lignin density |
| US10240164B2 (en) | 2012-12-05 | 2019-03-26 | British American Tobacco (Investments) Limited | Transgenic plants having altered lignin density |
| WO2018148169A1 (en) | 2017-02-07 | 2018-08-16 | University Of Kentucky Research Foundation | Method |
| US11999960B2 (en) | 2017-02-07 | 2024-06-04 | University Of Kentucky Research Foundation | Method of producing tobacco plants with increased sucrose ester content |
| WO2018237107A1 (en) | 2017-06-23 | 2018-12-27 | University Of Kentucky Research Foundation | Method |
| US12139718B2 (en) | 2017-06-23 | 2024-11-12 | University Of Kentucky Research Foundation | Methods of decreasing total alkaloid content in tobacco |
| WO2021205000A2 (en) | 2020-04-09 | 2021-10-14 | R.J. Reynolds Tobacco Company | Method |
Also Published As
| Publication number | Publication date |
|---|---|
| GB2197653B (en) | 1991-04-24 |
| GB8626862D0 (en) | 1986-12-10 |
| GB8725852D0 (en) | 1987-12-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB2197653A (en) | Gene fusion comprising beta -glucuronidase | |
| Jefferson et al. | GUS fusions: beta‐glucuronidase as a sensitive and versatile gene fusion marker in higher plants. | |
| CA2216244C (en) | Als3 promoter | |
| US5432081A (en) | Host cells transformed with the E. coli glucoronide permease gene | |
| US5290924A (en) | Recombinant promoter for gene expression in monocotyledonous plants | |
| KR100228918B1 (en) | Chimeric plant genes based on upstream regulatory elements of helianthin | |
| Dekeyser et al. | Transient gene expression in intact and organized rice tissues. | |
| Jefferson | Plant reporter genes: the GUS gene fusion system | |
| AU643521B2 (en) | A recombinant promoter for gene expression in monocotyledonous plants | |
| Facciotti et al. | Light-inducible expression of a chimeric gene in soybean tissue transformed with Agrobacterium | |
| EP0353908A2 (en) | DNA constructs and plant incorporating them | |
| Taniguchi et al. | The promoter for the maize C4 pyruvate, orthophosphate dikinase gene directs cell-and tissue-specific transcription in transgenic maize plants | |
| AU645990B2 (en) | Regulatory DNA sequence | |
| WO1993006711A1 (en) | Tomato acid invertase gene | |
| CA2151146C (en) | Use of a dna sequence coding for an oxalic acid degrading protein as a selection gene | |
| Quandt et al. | Tissue-specific activity and light-dependent regulation of a soybean rbcS promoter in transgenic tobacco plants monitored with the firefly luciferase gene | |
| CN107058317B (en) | A kind of pollen specific promoter and its application | |
| KR20020055540A (en) | Promotor system of translationally controlled tumor protein gene | |
| US7557264B2 (en) | Gossypium hirsutum tissue-specific promoters and their use | |
| EP2423316B1 (en) | Method for determining meiotic recombination frequencies in plants | |
| AU695325B2 (en) | Expression control polynucleotides derived from spliceosomal protein gene promoters | |
| US7202355B2 (en) | DNA sequence regulating plant fruit-specific expression | |
| OĞRAŞ et al. | Expression and inheritance of GUS gene in transgenic tobacco plants | |
| US5824865A (en) | Chimeric plant genes based on upstream regulatory elements of helianthinin | |
| JPWO2003004649A1 (en) | Promoters that express foreign genes at the root and shoot apex |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 711B | Application made for correction of error (sect. 117/77) | ||
| 727A | Application for amendment of specification now open to opposition (sect. 27/1977) | ||
| 727B | Case decided by the comptroller ** specification amended (sect. 27/1977) | ||
| SP | Amendment (slips) printed | ||
| 732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
| 732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
| 732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
| PE20 | Patent expired after termination of 20 years |
Effective date: 20071103 |